Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ELAFIBRANOR
- A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
- A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet
- Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
- Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers
- Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin
- Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)
- Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)
- Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients
- Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients
- Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Clinical trials list
click for details